Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer (Q36621469)

15 August 2017

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer (English)

1 reference

15 August 2017

1 reference

9

Vincent-Salomon A

1 reference

15 August 2017

Pierga JY

1

1 reference

15 August 2017

Mouret E

2

1 reference

15 August 2017

Diéras V

3

1 reference

15 August 2017

Laurence V

4

1 reference

15 August 2017

Beuzeboc P

5

1 reference

15 August 2017

Dorval T

6

1 reference

15 August 2017

Palangié T

7

1 reference

15 August 2017

Jouve M

8

1 reference

15 August 2017

Scholl S

10

1 reference

15 August 2017

Extra JM

11

1 reference

15 August 2017

Asselain B

12

1 reference

15 August 2017

Pouillart P

13

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

11

1 reference

15 August 2017

1480-1487

1 reference

The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Toxicity and response criteria of the Eastern Cooperative Oncology Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Evaluation of survival data and two new rank order statistics arising in its consideration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363409

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

28 June 2018

1 reference

12 December 2020

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome

1 reference

12 December 2020

Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach

1 reference

12 December 2020

The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma

1 reference

12 December 2020

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1 reference

12 December 2020

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

12 December 2020

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

12 December 2020

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer

1 reference

12 December 2020

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma

1 reference

12 December 2020

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

12 December 2020

Discouraging news for high-dose chemotherapy in high-risk breast cancer

1 reference

12 December 2020

The sentinel node in breast cancer--a multicenter validation study

1 reference

12 December 2020

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas

1 reference

12 December 2020

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer

1 reference

12 December 2020

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

12 December 2020

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

12 December 2020

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy

1 reference

12 December 2020

Prediction of response to primary chemotherapy for operable breast cancer

1 reference

12 December 2020

Treatment of curable carcinoma of the breast

1 reference

12 December 2020

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1 reference

12 December 2020

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

12 December 2020

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

12 December 2020

Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy

1 reference

12 December 2020

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

12 December 2020

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1 reference

12 December 2020

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

12 December 2020

Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1461

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11076657

1 reference